Brain cancer drugs approved in England

Apr 11, 2007

England's National Institute for Health and Clinical Excellence has removed a ban on two drugs that may help patients with rare life-threatening brain cancer.

Temodal and Gliadel may now be obtained through the National Health Service. The 2005 ban was based on cost-effectiveness.

The Times of London says the ban caused anger because Temodal was actually invented by British scientists with funding from Cancer Research UK.

Gliadel is a wafer that, when placed at the site where a brain tumor was removed, clears remaining cancer cells and keeps the tumor from recurring, the newspaper said.

Both drugs have been available in the United States and Canada.

Ella Pybus, spokeswoman for a consortium of cancer charities, said, "Everyone is relieved."

She said there is "solid evidence" the drugs help patients.

Copyright 2007 by United Press International

Explore further: Acne pill benefits outweigh blood clot risk: EU agency

add to favorites email to friend print save as pdf

Related Stories

3Qs: What's next for Lance Armstrong?

Jan 24, 2013

Road racing cyclist Lance Arm­strong, who won the Tour de France a record seven con­sec­u­tive times after beating tes­tic­ular cancer in the late 1990s, has report­edly admitted to using performance-​​enhancing ...

Lessons from herbicide tolerance

Aug 24, 2012

(Phys.org)—Polyamines are widespread and important organic compounds involved in multiple cellular processes in living organisms. Their levels are highly regulated through a combination of processes including ...

Philip Morris fights Australian packaging rules

Jun 27, 2011

(AP) -- Tobacco giant Philip Morris launched legal action on Monday against the Australian government over the country's plans to strip company logos from cigarette packages and replace them with grisly images ...

FDA: Breast implant problems grow with time

Jun 22, 2011

Don't expect breast implants to last for life, the government warned Wednesday: About 1 in 5 women who receive them for cosmetic reasons will have them removed within 10 years, and those odds are even higher ...

Recommended for you

First influenza vaccine brought to clinical testing

May 17, 2013

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Aspirin not always best treatment for many individuals

May 16, 2013

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

FDA: lower ambien's dose to prevent drowsy driving

May 15, 2013

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

Simponi approved for ulcerative colitis

May 15, 2013

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

FDA approves genetic test for lung cancer drug

May 14, 2013

The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.

User comments : 0

More news stories

Morocco to harness the wind in energy hunt

Morocco is ploughing ahead with a programme to boost wind energy production, particularly in the southern Tarfaya region, where Africa's largest wind farm is set to open in 2014.

Galaxy's Ring of Fire

Johnny Cash may have preferred this galaxy's burning ring of fire to the one he sang about falling into in his popular song. The "starburst ring" seen at center in red and yellow hues is not the product of ...